DERMATOLOGY UPDATE SPONSOR Arcutis Biotherapeutics

Arcutis Biotherapeutics (Nasdaq: ARQT) is a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology.

We are focused on filling the innovation gap in medical dermatology drug development by applying our deep clinical, product development and commercial expertise in dermatology to develop best-in-class therapies against biologically validated targets.

SUBSCRIBE TO DERMATOLOGY UPDATE NEWSLETTER

Keep up to date: